Meneldor
Druten, Gelderlandmeneldor.nl
Overview
Meneldor is a venture capital firm founded in 2016. It invests in early-stage biotechnology and pharmaceutical companies that (re)develop (New) Biological or Chemical Molecular Entities, that have outstanding technology with strong IP, address significant unmet medical needs and commercially attractive markets. The firm thoroughly studies the science behind her potential portfolio companies and assesses key aspects such as IP, medical need, addressable markets, competition, risk, management, financial needs, and valuation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TIBEAY Biosciences | Apr 2026 | VC Round | Co-investor |
| Tagworks Pharmaceuticals | Jun 2023 | Series A | Co-investor |
| Hemispherian AS | Nov 2022 | Series A | Lead |
| Hemispherian AS | May 2022 | Seed | Lead |
| Tagworks Pharmaceuticals | Nov 2021 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
